Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.
Saved in:
| Title: | Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial. |
|---|---|
| Authors: | Mukohara T; National Cancer Center Hospital East, Kashiwa, Japan., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Sommerhalder D; NEXT Oncology, San Antonio, TX, USA., Yonemori K; National Cancer Center Hospital, Tokyo, Japan., Hamilton E; Sarah Cannon Research Institute, Nashville, TN, USA., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim JH; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Iwata H; Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan., Yamashita T; Kanagawa Cancer Center, Yokohama, Japan., Layman RM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mita M; Hoag Family Cancer Institute, Newport Beach, CA, USA., Clay T; Saint John of God Subiaco Hospital, Perth, Western Australia, Australia., Chae YS; Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Oakman C; Western Health, Sunshine Hospital, St Albans, Victoria, Australia., Yan F; Swedish Cancer Institute, First Hill-True Family Women's Cancer Center, Seattle, WA, USA., Kim GM; Yonsei University College of Medicine, Seoul, Republic of Korea., Im SA; Seoul National University Hospital, Seoul National University College of Medicine, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lindeman GJ; Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Rugo HS; University of California, San Francisco, CA, USA., Liyanage M; Pfizer, San Diego, CA, USA., Saul M; Pfizer, San Diego, CA, USA., Le Corre C; Pfizer, San Diego, CA, USA., Skoura A; Pfizer, Collegeville, PA, USA., Liu L; Pfizer, San Diego, CA, USA., Li M; Pfizer, San Francisco, CA, USA. meng.li7@pfizer.com., LoRusso PM; Yale School of Medicine, New Haven, CT, USA. patricia.lorusso@yale.edu. |
| Source: | Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2371. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38914862 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<superscript>+</superscript>HER2<superscript>-</superscript> metastatic breast cancer: a phase 1 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mukohara+T%22">Mukohara T</searchLink>; National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Park+YH%22">Park YH</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Sommerhalder+D%22">Sommerhalder D</searchLink>; NEXT Oncology, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yonemori+K%22">Yonemori K</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamilton+E%22">Hamilton E</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SB%22">Kim SB</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+T%22">Yamashita T</searchLink>; Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Layman+RM%22">Layman RM</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mita+M%22">Mita M</searchLink>; Hoag Family Cancer Institute, Newport Beach, CA, USA.<br /><searchLink fieldCode="AU" term="%22Clay+T%22">Clay T</searchLink>; Saint John of God Subiaco Hospital, Perth, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Chae+YS%22">Chae YS</searchLink>; Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oakman+C%22">Oakman C</searchLink>; Western Health, Sunshine Hospital, St Albans, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Yan+F%22">Yan F</searchLink>; Swedish Cancer Institute, First Hill-True Family Women's Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+GM%22">Kim GM</searchLink>; Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Im+SA%22">Im SA</searchLink>; Seoul National University Hospital, Seoul National University College of Medicine, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lindeman+GJ%22">Lindeman GJ</searchLink>; Peter MacCallum Cancer Centre and Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liyanage+M%22">Liyanage M</searchLink>; Pfizer, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Saul+M%22">Saul M</searchLink>; Pfizer, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Le+Corre+C%22">Le Corre C</searchLink>; Pfizer, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Skoura+A%22">Skoura A</searchLink>; Pfizer, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Pfizer, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Pfizer, San Francisco, CA, USA. meng.li7@pfizer.com.<br /><searchLink fieldCode="AU" term="%22LoRusso+PM%22">LoRusso PM</searchLink>; Yale School of Medicine, New Haven, CT, USA. patricia.lorusso@yale.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2371. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38914862 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-024-03129-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2371 Titles: – TitleFull: Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mukohara T – PersonEntity: Name: NameFull: Park YH – PersonEntity: Name: NameFull: Sommerhalder D – PersonEntity: Name: NameFull: Yonemori K – PersonEntity: Name: NameFull: Hamilton E – PersonEntity: Name: NameFull: Kim SB – PersonEntity: Name: NameFull: Kim JH – PersonEntity: Name: NameFull: Iwata H – PersonEntity: Name: NameFull: Yamashita T – PersonEntity: Name: NameFull: Layman RM – PersonEntity: Name: NameFull: Mita M – PersonEntity: Name: NameFull: Clay T – PersonEntity: Name: NameFull: Chae YS – PersonEntity: Name: NameFull: Oakman C – PersonEntity: Name: NameFull: Yan F – PersonEntity: Name: NameFull: Kim GM – PersonEntity: Name: NameFull: Im SA – PersonEntity: Name: NameFull: Lindeman GJ – PersonEntity: Name: NameFull: Rugo HS – PersonEntity: Name: NameFull: Liyanage M – PersonEntity: Name: NameFull: Saul M – PersonEntity: Name: NameFull: Le Corre C – PersonEntity: Name: NameFull: Skoura A – PersonEntity: Name: NameFull: Liu L – PersonEntity: Name: NameFull: Li M – PersonEntity: Name: NameFull: LoRusso PM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 30 – Type: issue Value: 8 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |